Meningococcal B Strain Vaccination

The Hon. C.M. SCRIVEN (14:36): Further supplementary: how much funding has the government allocated for this program?

The Hon. S.G. WADE (Minister for Health and Wellbeing) (14:36): Considering that I have already said that we will be awaiting the expert working group report to consider the options and consider the costs involved, the costs will become clear as the options are determined.

The PRESIDENT: One further supplementary, the Hon. Ms Scriven.